Aerovate Therapeutics Stock (NASDAQ: AVTE) stock price, news, charts, stock research, profile.
You can purchase shares of Aerovate Therapeutics (NASDAQ:AVTE) through any online brokerage.
Other companies in Aerovate Therapeutics’s space includes: Burning Rock Biotech (NASDAQ:BNR), Armata Pharmaceuticals (AMEX:ARMP), Citius Oncology (NASDAQ:CTOR), Inovio Pharmaceuticals (NASDAQ:INO) and OS Therapies (AMEX:OSTX).
Aerovate Therapeutics has a consensus price target of $11.75.
The stock price for Aerovate Therapeutics (NASDAQ: AVTE) is $2.5305 last updated December 20, 2024 at 4:01 PM EST.
There are no upcoming dividends for Aerovate Therapeutics.
Aerovate Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Aerovate Therapeutics.
Aerovate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.